Condition
SARS-CoV-2 Virus
Total Trials
7
Recruiting
1
Active
3
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed4
Active Not Recruiting2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT05543616Phase 3Active Not RecruitingPrimary
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
NCT05765396Active Not Recruiting
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
NCT06784739Recruiting
COMMUNITY - the COVID-19 Immunity Study
NCT06027398Not ApplicableCompletedPrimary
SARS-COV-2 Detection From Used Surgical Mask
NCT04609085CompletedPrimary
SARS-COV2 Pandemic Serosurvey in a Rare Disease Population
NCT04334954CompletedPrimary
SARS-COV2 Pandemic Serosurvey and Blood Sampling
NCT05060926Completed
Intubation Prediction in COVID-19 Patients Treated With Awake Prone Positioning
Showing all 7 trials